What is Microbot Medical?
Founded in 2010 and publicly traded on NASDAQ, Microbot Medical is dedicated to advancing medical device manufacturing through proprietary micro-robotic platforms. The company's focus on developing innovative solutions for both natural and artificial lumens positions it at the forefront of a burgeoning field. Its Multi Generation Pipeline Portfolio aims to enhance patient outcomes and broaden access to cutting-edge healthcare interventions.
How much funding has Microbot Medical raised?
Microbot Medical has raised a total of $9M across 1 funding round:
Stock Offering
$9M
Stock Issuance/Offering (2020): $9M, investors not publicly disclosed
What's next for Microbot Medical?
The recent major strategic investment signals a critical phase for Microbot Medical, likely indicating a move towards scaling operations or advancing its pipeline towards clinical trials. This influx of capital, part of its $9M in total backing, will be instrumental in furthering its research and development efforts in micro-robotic medical technologies. The company's trajectory suggests a strong emphasis on innovation and market penetration within the specialized medical device industry.
See full Microbot Medical company page
